汉森制药 (002412)

Hunan Hansen Pharmaceutical Co.,Ltd.

ASZ

Tags

Innovative DrugsPharmaceutical ManufacturingInvestments in Financial InstitutionsHelicobacter PyloriMicro and Small Cap StocksMicro Cap Selected StocksHepatitis ConceptMargin Trading and Securities Lending

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 50320.00
  • Circulating A-Shares(W): 49784.50
  • Earnings Per Share(RMB): 0.1640
  • Net Assets Per Share(RMB): 4.4929
  • Operating Revenue(W RMB): 74079.39
  • Total Profit(W RMB): 11311.46
  • Net Profit Attributable to Parent(W RMB): 8252.52
  • Net Profit Growth Rate(%): -36.88
  • Weighted Return on Equity(%): 3.6900
  • Operating Cash Flow Per Share(RMB): 0.3220
  • Undistributed Profit Per Share(RMB): 2.6372
  • Capital Reserve Per Share(RMB): 0.4653

2. Main Business

The main business covers:

  • Production of traditional Chinese medicine preparations
  • Production of chemical drugs

3. Company Basic Information

  • Company Name: Hunan Hansen Pharmaceutical Co., Ltd.
  • Listing Date: 2010-05-25
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 2688 Yincheng Avenue, Heshan District, Yiyang City, Hunan Province
  • Website: www.hansenzy.com
  • Company Profile：The issuer was established through the overall change of Hansen Co., Ltd. Hansen Co., Ltd. was established on January 21, 1998, initially named Hunan Yiyang Pharmaceutical Co., Ltd., and renamed Hunan Hansen Pharmaceutical Co., Ltd. on March 2, 2000. Approved by the shareholders' meeting of Hansen Co., Ltd. on January 4, 2008, and the company's promoter meeting on January 20, 2008, the original shareholders of Hansen Co., Ltd. acted as promoters, using the net assets of 70,306,456.30 RMB audited by Lianda as of December 31, 2007, as the base, converted into 55,000,000 shares of the joint-stock company, with the remaining 15,306,456.30 RMB converted into capital reserve. On January 22, 2008, Lianda examined and verified the above capital contribution of the promoters and issued the Lianda Verification Report [2008] No. A1008, confirming that the shareholders' contributions were genuine and fully paid. On January 22, 2008, the issuer obtained the Business License with registration number 430900000005212.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Hainan Hansen Holding (Limited Partnership) General Legal Person 21200.62 42.58
2 Shanghai Fosun Pharmaceutical Industry Development Co., Ltd. General Legal Person 2426.38 4.87
3 Jinyuan Shun'an Yuanqi Flexible Allocation Hybrid Securities Investment Fund Fund 211.40 0.42
4 Goldman Sachs & Co. LLC QFII 185.50 0.37

5. Concept Sectors

  • Helicobacter Pylori
  • Hepatitis Concept
  • Innovative Drugs
  • Margin Trading & Securities Lending
  • Financial Investment
  • Micro-cap Selection
  • Micro & Small Cap Stocks

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information